| Contributors List | |
Part 1 | History and Development of Transfusion Medicine | 1 |
1 | From Blood Transfusion to Transfusion Medicine / Alice Maniatis | 3 |
Part 2 | Allogeneic Blood Usage---Risks and Benefits | 9 |
2 | Allogeneic Blood Components / Sheila MacLennan | 11 |
3 | Current Information on the Infectious Risks of Allogeneic Blood Transfusion / John A. J. Barbara | 21 |
4 | Immunological Complications of Blood Transfusion / Marcela Contreras | 31 |
5 | Immunomodulation and Allogeneic Blood Transfusion / Anneke Brand | 47 |
6 | Pathogen Inactivation of Blood Components / Chris Prowse | 60 |
7 | The Benefits of Allogeneic Erythrocyte Transfusion: What Evidence Do We Have? / Benjamin Thomas | 68 |
Part 3 | Volume Replacement | 83 |
Section 1 | Plasma and Albumin | 85 |
8 | Plasma and Albumin / Philippe L. Baele | 87 |
Section 2 | Crystalloids and Synthetic Colloids | 109 |
9 | Pharmacology of Intravenous Fluids / Michael F.M. James | 111 |
10 | Crystalloids versus Colloids: The Controversy / Hengo Haljamae | 119 |
11 | Effects of Synthetic Colloids on Hemostasis / Gisela Scharbert | 137 |
12 | Hydroxyethyl Starch and Renal Dysfunction / Bertrand Guidet | 150 |
13 | Choice of a Synthetic Colloid for Surgery / Joachim Boldt | 158 |
14 | Choice of Colloid for Intensive Care Patients / Yalcin Inel | 168 |
15 | Hypertonic Saline Solutions for the Initial Treatment of Patients with Traumatic Injuries / Michael A. Dubick | 179 |
16 | Hyperchloremic Acidosis / Andre Vercueil | 194 |
Part 4 | Tolerance of Anemia | 203 |
17 | Basic Principles of Oxygen Transport and Calculations / Davide Simion | 205 |
18 | Assessment of Tissue Oxygenation / Philippe Van der Linden | 210 |
19 | Tissue Oxygenation and Blood Transfusion / Joachim Boldt | 218 |
20 | Anemia and Cardiovascular Disease / Helen Melita | 229 |
Part 5 | Perioperative Hemostasis | 253 |
21 | Monitoring of Hemostasis in the Perioperative Setting / Eva Schaden | 255 |
22 | Antifibrinolyties in Open-Heart Surgery / Wulf Dietrich | 267 |
23 | Efficacy and Safety of Recombinant Activated Factor VII to Control Bleeding in Nonhemophiliac Patients / Philippe Van der Linden | 278 |
Part 6 | Transfusion Triggers | 293 |
24 | Role of Hemoglobin/Hematocrit / A. Gerson Greenburg | 295 |
25 | Calculation of Blood Loss / Mark E. Brecher | 303 |
26 | Management of Massive Transfusion / Marc Samama | 313 |
Part 7 | Alternatives to Allogeneic Blood Transfusion | 329 |
Section 1 | Pharmaceutical Approaches | 331 |
27 | Iron Deficiency: Causes, Diagnosis, and Management / Elvira Bisbe | 335 |
28 | Current Status of Perisurgical Erythropoietin Therapy / Lawrence T. Goodnough | 350 |
29 | Erythropoietin and Iron Therapy in Patients with Renal Failure / Francesco Locatelli | 357 |
30 | Hemoglobin-based Blood Substitutes / Maurice Lamy | 368 |
31 | Perfluorocarbon Emulsions / Pedro Cabrales | 380 |
Section 2 | Surgical Techniques | 389 |
32 | Minimally Invasive Cardiac Surgery: Impact on Blood Loss and Transfusion / Fraser Rubens | 391 |
33 | Adjunctive Strategies to Impact Blood Transfusion in Cardiac Surgery / Fraser Rubens | 408 |
Section 3 | Anesthetic Techniques | 419 |
34 | Anesthetic Techniques to Reduce Blood Loss / Dafydd Thomas | 421 |
35 | Controlled Hypotension Decreases Blood Transfusion Requirement: Fact or Fallacy? / Richard P. Dutton | 430 |
36 | Acute Normovolemic Hemodilution / Philippe Van der Linden | 439 |
37 | Hyperoxic Hemodilution / Oliver Habler | 450 |
38 | Intraoperative and Postoperative Cell Salvage / Hans Gombotz | 458 |
Section 4 | Special Settings | 475 |
39 | Anemia and Red Blood Transfusion in Critical Care / Tim Walsh | 477 |
40 | Red Blood Cell Transfusions and Alternatives to Treat the Anemia of Prematurity / Ronald G. Strauss | 490 |
41 | Transfusion Alternatives in Orthopedic Surgery / Jorge Cuenca | 498 |
42 | Transfusion Alternatives in Obstetrics / Christian Breymann | 509 |
Part 8 | Legal and Ethical Issues in Transfusion Medicine | 521 |
43 | Ethical Aspects of Informed Consent: American Models / Ronald E. Domen | 523 |
44 | Blood Transfusions, Jehovah's Witnesses, and the American Patients' Rights Movement / Charles H. Baron | 531 |
Part 9 | Cost Issues | 557 |
45 | The Cost and Cost-Effectiveness of Allogeneic and Autologous Blood / Brian Custer | 559 |
46 | Autologous Blood Predonation in Cardiac Surgery / Wulf Dietrich | 569 |
47 | Cost-Effectiveness of Pharmacological Alternatives / Brian Hutton | 575 |
| Index | 581 |